Dr. Havens is a naturopathic physician and clinical researcher, whose practice focuses on evidence-based, precision complimentary and integrative medicine. She uses next generation sequencing (NGS) and multi-platform tumor biomarker analysis to inform treatment recommendations tailored specifically for each patient’s tumor biology.
After graduating from Southwest College of Naturopathic Medicine and Health Sciences, she was awarded an NIH/ NRSA clinical research fellowship at the University of Washington in Seattle and then continued her clinical training as a Resident in Naturopathic Oncology at the Cancer Treatment Centers of America in Philadelphia.
Prior to becoming a naturopathic physician, Dr. Havens received her doctoral training at the University of Virginia in the Department of Molecular and Cancer Biology after which she continued as a researcher specializing in DNA-based molecular diagnostics. Her background in cancer biology and genomics, coupled with her training as a naturopathic physician, makes her uniquely qualified to create integrative treatment protocols driven by patient-specific genetic analysis.
Her current research is focused on the role of Mistletoe (Viscum album) therapy in modulation of progression of disease and treatment resistance in patients using conventional chemotherapeutics and targeted therapies.
In addition to her integrative oncology practice at SCNM Medical Center, Dr. Havens also works at Children’s Hospital of Wisconsin in the Division of Pediatric Oncology. She is currently developing an integrative medicine model of care to support pediatric patients with cancer across their continuum of conventional therapy. Additionally, she is developing a research infrastructure to assess the safety and efficacy of acupressure for the treatment of refractory pain and nausea in pediatric oncology populations.
AANP, American Association of Naturopathic Physicians, AzNMA, Arizona Naturopathic Medical Association, OncANP, Oncology Association of Naturopathic Physicians, SIO, Society of Integrative Oncology, American Society of Clinical Oncology, International Congress on Integrative Medicine and Health
Molecular biogrouping of pathogenic Yersinia enterocolitica; Evaluation of immunohistochemistry in identifying Bartonella henselae in catscratch disease; Pathogenic Yersinia DNA in Intestinal Specimens of Pediatric Patients with Crohn's Disease. Fetal Pediatr Pathol.